Inhibrx Biosciences, Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 13/08/2026 | Mar 2026Filed 13/08/2026 | Sep 2025Filed 14/11/2025 | Jun 2025Filed 13/08/2026 | Mar 2025Filed 13/08/2026 | Sep 2024Filed 14/11/2025 | Jun 2024Filed 14/11/2025 | Mar 2024Filed 14/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $0 | — | $0 | $1.3 | $0 | $0 | $0.1 | $0 | |
| −$37 | −$33 | −$35 | −$29 | −$43 | −$44 | $1,858 | −$79 | |
| −$2.34 | −$2.15 | −$2.28 | −$1.85 | −$2.80 | −$2.84 | $125.48 | −$5.77 | |
| 16 | 16 | 15 | 15 | 15 | 15 | 15 | 14 |
Trend